-
DE
Meconium ileus is a bowel obstruction in newborns caused by abnormally thick meconium blocking the small intestine. It is often the first sign of cystic fibrosis.
Meconium ileus is a bowel obstruction in newborns caused by abnormally thick meconium blocking the small intestine. It is often the first sign of cystic fibrosis.
Meconium ileus is a serious intestinal condition in newborns in which the meconium – the infant first stool – becomes so thick and sticky that it completely blocks the small intestine, most commonly the terminal ileum. This blockage causes a mechanical bowel obstruction (ileus) that becomes symptomatic immediately after birth or within the first few hours of life.
In approximately 80–90% of cases, meconium ileus is associated with the inherited disease cystic fibrosis. Due to a genetic defect in the CFTR protein (Cystic Fibrosis Transmembrane Conductance Regulator), the pancreas produces insufficient digestive enzymes, leading to abnormally thick meconium that cannot pass through the intestine normally.
In uncomplicated meconium ileus, the obstruction is caused solely by the impacted thick meconium, without additional complications such as perforation or bowel necrosis.
In complicated meconium ileus, serious additional complications are present, including:
The most common cause of meconium ileus is cystic fibrosis, an autosomal recessive inherited disorder. The defective CFTR protein results in meconium that lacks sufficient water and digestive enzymes, giving it an abnormally thick consistency that blocks the intestine.
In rare cases, meconium ileus can occur without cystic fibrosis, for example in:
Symptoms of meconium ileus typically appear shortly after birth:
In complicated cases, signs of peritonitis may additionally appear, such as redness and rigidity of the abdominal wall.
Diagnosis of meconium ileus is based on several investigations:
Abdominal distension, doughy palpable bowel loops, and failure to pass meconium are key clinical findings pointing toward the diagnosis.
When cystic fibrosis is suspected, a sweat chloride test and genetic analysis for CFTR mutations are performed. Newborn screening programs in many countries also include screening for cystic fibrosis.
In uncomplicated meconium ileus, non-surgical management is often possible. A hyperosmolar contrast enema (e.g., with Gastrografin) is administered. The contrast agent draws water into the bowel, softening the impacted meconium and promoting its passage. This procedure may be repeated if necessary. Intensive monitoring with adequate intravenous fluid replacement is essential throughout.
In complicated meconium ileus or when conservative treatment fails, surgical intervention is required. Surgical options include:
When cystic fibrosis is the underlying cause, it requires long-term management including pancreatic enzyme replacement therapy, physiotherapy, nutritional support, and – where applicable CFTR mutations exist – treatment with CFTR modulators (e.g., ivacaftor, lumacaftor).
With modern medical care, the prognosis for meconium ileus has improved significantly. Survival rates exceed 90% with timely treatment. Long-term outcomes are largely determined by the course of the underlying cystic fibrosis.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.